6.535
Schlusskurs vom Vortag:
$6.73
Offen:
$6.65
24-Stunden-Volumen:
327.19K
Relative Volume:
0.75
Marktkapitalisierung:
$154.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-52.07M
KGV:
-31.46
EPS:
-0.2077
Netto-Cashflow:
$-44.93M
1W Leistung:
-11.97%
1M Leistung:
-11.61%
6M Leistung:
-9.67%
1J Leistung:
-17.56%
Cybin Inc Stock (CYBN) Company Profile
Firmenname
Cybin Inc
Sektor
Branche
Telefon
908 764 8385
Adresse
100 King Street West, Suite 5600, Toronto
Vergleichen Sie CYBN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
CYBN
Cybin Inc
|
6.53 | 158.76M | 0 | -52.07M | -44.93M | -0.2077 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.16 | 101.56B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
458.34 | 59.25B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.57 | 60.77B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
762.01 | 45.95B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
343.83 | 37.61B | 3.81B | -644.79M | -669.77M | -6.24 |
Cybin Inc Stock (CYBN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-13 | Eingeleitet | Guggenheim | Buy |
2021-11-19 | Herabstufung | Maxim Group | Buy → Hold |
Cybin Inc Aktie (CYBN) Neueste Nachrichten
Cybin completes phase 2 enrollment evaluating CYB004 for the treatment of generalized anxiety disorder - MarketScreener
300M Anxiety Patients Could Benefit: Cybin's Novel DMT Drug Reaches Key Trial Milestone - Stock Titan
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Can Cybin Inc. lead its sector in growthQuarterly Profit Report & Smart Swing Trading Alerts - classian.co.kr
Can Cybin Inc. reach all-time highs this yearخودرو بانک - خودرو بانک
Can swing trading help recover from Cybin Inc. lossesJuly 2025 Outlook & Weekly Return Optimization Alerts - Newser
What dividend growth rate does Cybin Inc. offerWeekly Trade Recap & High Conviction Buy Zone Picks - خودرو بانک
Is Cybin Inc. in a long term uptrendWeekly Market Outlook & High Accuracy Swing Trade Signals - خودرو بانک
Has Cybin Inc. Stock Ever Crashed Historical Volatility ReviewJuly 2025 PostEarnings & Detailed Earnings Play Strategies - Newser
Why Cybin Inc. is moving todayMarket Trend Review & Low Drawdown Trading Techniques - Newser
Will Cybin Inc. price bounce be sustainableTake Profit & Growth Oriented Trade Recommendations - Newser
Is Cybin Inc. forming a breakout patternTrade Risk Summary & High Accuracy Buy Signal Tips - خودرو بانک
Chipmakers Recap: Can Cybin Inc. lead its sector in growthDay Trade & Verified Swing Trading Watchlist - خودرو بانک
Real time social sentiment graph for Cybin Inc.Market Growth Summary & Stock Portfolio Risk Control - Newser
Should you wait for a breakout in Cybin Inc.July 2025 Decliners & Expert Verified Stock Movement Alerts - Newser
Public market insider buying at Cybin (CYBN) - The Globe and Mail
What to expect from Cybin Inc. in the next 30 daysMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser
Can Cybin Inc. be the next market leader2025 Short Interest & Accurate Entry and Exit Point Alerts - خودرو بانک
What does recent volatility data suggest for Cybin Inc.Weekly Profit Summary & Weekly High Potential Stock Alerts - Newser
Cybin Inc. to Present at H.C. Wainwright Global Investment Conference - citybuzz -
Cybin to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - FinancialContent
Is Cybin Inc. a good ESG investmentJuly 2025 Market Mood & Community Trade Idea Sharing Platform - خودرو بانک
Is Cybin Inc. affected by consumer sentimentWeekly Risk Report & AI Powered Buy/Sell Recommendations - خودرو بانک
Cybin Inc. shares rise 3.49% premarket after announcing participation in Cantor Global Healthcare Conference. - AInvest
Exit strategy if you’re trapped in Cybin Inc.Weekly Trade Analysis & Verified Trade Idea Suggestions - Newser
Cybin Inc. shares rise 1.00% after-hours as Chief Medical Officer to participate in Cantor Global Healthcare Conference. - AInvest
Analyzing drawdowns of Cybin Inc. with statistical toolsGlobal Markets & Smart Money Movement Tracker - Newser
Cybin Inc. to Present at Cantor Global Healthcare Conference, Highlighting Neuropsychiatry Pipeline - citybuzz -
Is Cybin Inc. a potential multi baggerWeekly Earnings Recap & AI Enhanced Market Trend Forecasts - خودرو بانک
Cybin to Participate in Cantor Global Healthcare Conference 2025 with Fireside Chat by CMO Amir Inamdar - AInvest
Cybin to Participate in the Cantor Global Healthcare Conference 2025 - FinancialContent
Regression analysis insights on Cybin Inc. performanceJuly 2025 Summary & High Conviction Buy Zone Alerts - Newser
Cybin Inc. (CYBN) Launches Global Phase 3 Trial for Breakthrough Depression Therapy - MSN
Will Cybin Inc. stock go up soonQuarterly Performance Summary & Daily Volume Surge Signals - Newser
Should you wait for a breakout in Cybin IncWeekly Gains Report & Community Consensus Trade Alerts - Newser
Visualizing Cybin Inc. stock with heatmapsLong Setup & Weekly Return Optimization Plans - Newser
Cybin Announces Shareholder Meeting Results and Strategic Developments - MSN
Volatility clustering patterns for Cybin Inc.Trade Risk Assessment & Precise Trade Entry Recommendations - Newser
Cybin to Participate in the Cantor Global Healthcare Conference 2025 | CYBN Stock News - GuruFocus
Is Cybin Inc. stock showing strong momentumProduct Launch & Safe Swing Trade Setups - خودرو بانک
Cybin Inc. shares rise 7.53% after-hours following CEO Doug Drysdale's resignation and Eric So's appointment as interim CEO. - AInvest
Cybin Inc. Announces Leadership Transition as Eric So Assumes Interim CEO Role - citybuzz -
Cybin (CYBN) CEO Steps Down; Shares React - GuruFocus
Cybin Chief Executive Doug Drysdale Steps Down; Eric So Named Interim CEO - MarketScreener
Cybin announces senior leadership changes - MarketScreener
Cybin Announces Senior Leadership Changes - Business Wire
Cybin Inc. recovery potential after sell offEarnings Overview Summary & AI Forecast Swing Trade Picks - Newser
Cybin Inc. (CYBN): A High-Potential Play in Psychedelic Psychiatry with Phase 3 Momentum and $500M in Backing - AInvest
Cybin Inc. Launches Global Phase 3 Trial for Breakthrough Depression Treatment, Secures $500M Financing - AInvest
Is Cybin Inc. stock overvalued or fairly pricedBond Market & Fast Gain Stock Tips - خودرو بانک
Cybin Announces Senior Leadership Changes | CYBN Stock News - GuruFocus
Finanzdaten der Cybin Inc-Aktie (CYBN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):